Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2025 07:00 ET | Source: Upstream Bio

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs
February 25, 2025 08:00 ET | Source: Upstream Bio

Upstream Bio to Present at Upcoming March Investor Conferences

Upstream Bio to Present at Upcoming March Investor Conferences
January 06, 2025 08:00 ET | Source: Upstream Bio

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 17, 2024 08:00 ET | Source: Upstream Bio

Upstream Bio Appoints Allison Ambrose as General Counsel

Upstream appoints Allison Ambrose as General Counsel
November 21, 2024 08:00 ET | Source: Upstream Bio

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

Upstream Bio CEO to participate in fireside chat at Piper Sandler
September 09, 2024 08:00 ET | Source: Upstream Bio, Inc.

Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress

Upstream gives oral presentation of clinical data for verekitug in patients with severe asthma at European Respiratory Society congress
May 15, 2024 07:00 ET | Source: Upstream Bio, Inc.

Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society (ATS) International Conference

Upstream Bio will present clinical data from dose-ranging study of verekitug (UPB-101) in adults with asthma at the American Thoracic Society conference